Ouster Seeks Shareholder Approval to Double Authorized Common Stock, Enabling Significant Future Dilution

summarizeSummary

Ouster, Inc. filed its definitive proxy statement, seeking shareholder approval to double its authorized common stock to 200 million shares, enabling significant future dilution, and to exculpate officers from certain fiduciary duty liabilities.

check_boxKey Events · Financing and Capital Events · OUST

• Shareholders to Vote on Doubling Authorized Shares

  Ouster is asking shareholders to approve an amendment to its Certificate of Incorporation to increase the number of authorized common stock from 100,000,000 to 200,000,000 shares. This definitive proxy statement follows the preliminary filing on April 17, 2026, finalizing the terms for the upcoming shareholder meeting.

• Significant Potential Dilution

  With 63,461,091 shares outstanding as of March 31, 2026, the proposed increase in authorized shares creates the potential for over 150% dilution if all newly authorized shares were issued. This provides the company with substantial flexibility for future capital raises, strategic transactions, or equity awards.

• Officer Exculpation Proposed

  The company also seeks shareholder approval for an amendment to exculpate officers from monetary liability for breaches of fiduciary duty of care, to the fullest extent permitted by Delaware law. This aligns officer protections with those already in place for directors.

• Director Re-election and Board Changes

  Shareholders will vote on the re-election of Phillip M. Eyler and Angus Pacala (CEO) as Class II Directors. Current director Virginia Boulet has not been nominated for re-election, leading to a minor board composition change.

auto_awesomeAnalysis · OUST · Technology

This definitive proxy statement formalizes Ouster's request for shareholder approval to significantly increase its authorized common stock from 100 million to 200 million shares. With approximately 63.5 million shares currently outstanding, this proposal, if approved, would authorize an additional 100 million shares, creating potential for over 150% dilution relative to the current outstanding share count. This move provides the company substantial flexibility for future financing activities, strategic acquisitions, or equity-based compensation, but signals a significant potential for dilution for existing shareholders. Additionally, the company is seeking to amend its Certificate of Incorporation to exculpate officers from liability for breaches of fiduciary duty of care, aligning their protections with those of directors, which is a notable corporate governance change.